In TCGA-CRC cohort, high LHFPL6 expression was significantly associated with worse disease-free survival (DFS: p = 0.0026), progress-free survival (PFS: p < 0.0001), and DSS (p = 0.0085) (Fig. 4D). The gene discussed is LHFPL6; the disease is colorectal carcinoma.